ADMA and oxidative stress

By Sydow K.   Munzel T.  

Atherosclerosis, Supplements, Vol. 4, Iss. 4, 2003-12 ,pp. : 41-51

Elsevier

Access to resources Recommend Favorite

Homocysteine and ADMA—emerging risk factors for cardiovascular disease?

By Hedner Thomas   Himmelmann Anders   Hansson Lennart  

Blood Pressure, Vol. 11, Iss. 4, 2002-07 ,pp. : 197-200

Informa Healthcare

Access to resources Recommend Favorite

Plasma Apelin and ADMA Levels in Patients with Essential Hypertension

By Sonmez Alper   Celebi Gurkan   Erdem Gokhan   Tapan Serkan   Genc Halil   Tasci Ilker   Ercin Cemal Nuri   Dogru Teoman   Kilic Selim   Uckaya Gokhan   Yilmaz Mahmut Ilker   Erbil Mehmet Kemal   Kutlu Mustafa  

Clinical and Experimental Hypertension, Vol. 32, Iss. 3, 2010-05 ,pp. : 179-183

Informa Healthcare

Access to resources Recommend Favorite

Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events - Does statin treatment influence plasma ADMA levels?

By Valkonen V.-P.   Laakso J.   Paiva H.   Lehtimaki T.   Lakka T.A.   Isomustajarvi M.   Ruokonen I.   Salonen J.T.   Laaksonen R.  

Atherosclerosis, Supplements, Vol. 4, Iss. 4, 2003-12 ,pp. : 19-22

Elsevier

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase

By Boger R.H.   Vallance P.   Cooke J.P.  

Atherosclerosis, Supplements, Vol. 4, Iss. 4, 2003-12 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite